BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chebotareva N, Vinogradov A, McDonnell V, Zakharova NV, Indeykina MI, Moiseev S, Nikolaev EN, Kononikhin AS. Urinary Protein and Peptide Markers in Chronic Kidney Disease. Int J Mol Sci 2021;22:12123. [PMID: 34830001 DOI: 10.3390/ijms222212123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Tain Y, Hsu C. Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease. Children 2022;9:1650. [DOI: 10.3390/children9111650] [Reference Citation Analysis]
2 Luu BE, Mossa AH, Cammisotto PG, Uri Saragovi H, Campeau L. Modulation of diabetic kidney disease markers by an antagonist of p75NTR in streptozotocin-treated mice. Gene 2022;838:146729. [PMID: 35835402 DOI: 10.1016/j.gene.2022.146729] [Reference Citation Analysis]
3 Lash LH. Lawrence Lash reports financial support was provided by National Institutes of Health. Cellular and Functional Biomarkers of Renal Injury and Disease. Current Opinion in Toxicology 2022. [DOI: 10.1016/j.cotox.2022.100348] [Reference Citation Analysis]